These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Estrogen receptor (ER) gene polymorphism may predict the bone mineral density response to raloxifene in postmenopausal women on chronic hemodialysis. Heilberg IP, Hernandez E, Alonzo E, Valera R, Ferreira LG, Gomes SA, Bellorin-Font E, Weisinger JR. Ren Fail; 2005; 27(2):155-61. PubMed ID: 15807179 [Abstract] [Full Text] [Related]
5. Early postmenopausal bone loss is associated with PvuII estrogen receptor gene polymorphism in Finnish women: effect of hormone replacement therapy. Salmén T, Heikkinen AM, Mahonen A, Kröger H, Komulainen M, Saarikoski S, Honkanen R, Mäenpää PH. J Bone Miner Res; 2000 Feb; 15(2):315-21. PubMed ID: 10703934 [Abstract] [Full Text] [Related]
6. Estrogen receptor gene polymorphisms and bone mineral density in Chinese postmenopausal women. Liu J, Zhu H, Zhu X, Dai M, Jiang L, Xu M, Chen J. Chin Med J (Engl); 2003 Mar; 116(3):364-7. PubMed ID: 12781038 [Abstract] [Full Text] [Related]
9. Estrogen receptor alpha and beta polymorphisms: is there an association with bone mineral density, plasma lipids, and response to postmenopausal hormone therapy? Silvestri S, Thomsen AB, Gozzini A, Bagger Y, Christiansen C, Brandi ML. Menopause; 2006 Mar; 13(3):451-61. PubMed ID: 16735942 [Abstract] [Full Text] [Related]
12. Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density and fracture risk in women: a meta-analysis. Ioannidis JP, Stavrou I, Trikalinos TA, Zois C, Brandi ML, Gennari L, Albagha O, Ralston SH, Tsatsoulis A, ER-alpha Genetics Meta-Analysis. J Bone Miner Res; 2002 Nov; 17(11):2048-60. PubMed ID: 12412813 [Abstract] [Full Text] [Related]
16. Polymorphisms in the CYP19 and AR genes--relation to bone mass and longitudinal bone changes in postmenopausal women with or without hormone replacement therapy: The Danish Osteoporosis Prevention Study. Tofteng CL, Kindmark A, Brändström H, Abrahamsen B, Petersen S, Stiger F, Stilgren LS, Jensen JE, Vestergaard P, Langdahl BL, Mosekilde L, Danish Osteoporosis Prevention Study. Calcif Tissue Int; 2004 Jan; 74(1):25-34. PubMed ID: 14517714 [Abstract] [Full Text] [Related]
17. Joint effects of the CYP1A1 MspI, ERalpha PvuII, and ERalpha XbaI polymorphisms on the risk of breast cancer: results from a population-based case-control study in Shanghai, China. Shen Y, Li DK, Wu J, Zhang Z, Gao E. Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):342-7. PubMed ID: 16492926 [Abstract] [Full Text] [Related]
19. Association of bone mineral density with polymorphism of the estrogen receptor gene. Kobayashi S, Inoue S, Hosoi T, Ouchi Y, Shiraki M, Orimo H. J Bone Miner Res; 1996 Mar; 11(3):306-11. PubMed ID: 8852941 [Abstract] [Full Text] [Related]
20. Prediction of bone mineral density from vitamin D receptor polymorphisms is uncertain in representative samples of Japanese Women. The Japanese Population-based Osteoporosis (JPOS) Study. Morita A, Iki M, Dohi Y, Ikeda Y, Kagamimori S, Kagawa Y, Matsuzaki T, Yoneshima H, Marumo F, JPOS Study Group. Int J Epidemiol; 2004 Oct; 33(5):979-88. PubMed ID: 15358739 [Abstract] [Full Text] [Related] Page: [Next] [New Search]